Table of Content

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 20

2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY SOURCES 22
2.1.1.1 Key data from secondary sources 23
2.1.2 PRIMARY SOURCES 23
2.1.2.1 Key data from primary sources 24
2.1.2.2 Key industry insights 25
2.2 MARKET SIZE ESTIMATION 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.4 ASSUMPTIONS FOR THE STUDY 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 35
4.1 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET OVERVIEW 35
4.2 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING (2019–2024) 36
4.3 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE & REGION (2018) 37
4.4 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 38

5 MARKET OVERVIEW 39
5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
5.2.1 MARKET DRIVERS 40
5.2.1.1 Growing number of cross-industry collaborations and partnerships 40
5.2.1.2 Need to control drug discovery & development costs and reduce time 41
5.2.1.3 Patent expiry 41
5.2.2 MARKET OPPORTUNITIES 42
5.2.2.1 Growing biotechnology industry 42
5.2.2.2 Emerging markets 42
5.2.3 MARKET CHALLENGES 42
5.2.3.1 Limited availability of data sets 42

6 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING 43
6.1 INTRODUCTION 44
6.2 SOFTWARE 44
6.2.1 BENEFITS OFFERED BY SOFTWARE IN DRUG DISCOVERY & STRONG DEMAND AMONG END USERS ARE DRIVING MARKET GROWTH 44
6.3 SERVICES 46
6.3.1 SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 46

7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY 48
7.1 INTRODUCTION 49
7.2 MACHINE LEARNING 49
7.2.1 INCREASING ADOPTION OF ML BY RESEARCH CENTERS & PHARMACEUTICAL COMPANIES TO SUPPORT THE GROWTH OF THIS SEGMENT 49
7.2.2 DEEP LEARNING 51
7.2.3 SUPERVISED LEARNING 54
7.2.4 REINFORCEMENT LEARNING 56
7.2.5 UNSUPERVISED LEARNING 57
7.2.6 OTHER MACHINE LEARNING TECHNOLOGIES 59
7.3 OTHER TECHNOLOGIES 61

8 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION 63
8.1 INTRODUCTION 64
8.2 IMMUNO-ONCOLOGY 64
8.2.1 HIGH PREVALENCE OF CANCER AND SHORTAGE IN THE SUPPLY OF CANCER DRUGS ARE THE KEY FACTORS DRIVING MARKET GROWTH 64
8.3 NEURODEGENERATIVE DISEASES 66
8.3.1 AI IS BEING USED TO RESOLVE EXISTING CHALLENGES IN NEUROLOGICAL DISEASE DRUG DEVELOPMENT 66
8.4 CARDIOVASCULAR DISEASES 68
8.4.1 RISING DEMAND FOR CVD DRUGS IS DRIVING MARKET GROWTH 68
8.5 METABOLIC DISEASES 70
8.5.1 ROLE OF AI IN UNCOVERING SMALL-MOLECULE THERAPIES IS DRIVING ITS ADOPTION IN THIS SEGMENT 70
8.6 OTHER APPLICATIONS 72

9 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER 74
9.1 INTRODUCTION 75
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 75
9.2.1 RISING DEMAND FOR SOLUTIONS TO CUT TIME AND COSTS OF DRUG DEVELOPMENT HAVE DRAWN END-USER ATTENTION TO AI 75
9.3 CONTRACT RESEARCH ORGANIZATIONS 78
9.3.1 GROWING TREND OF OUTSOURCING PROVIDES SIGNIFICANT OPPORTUNITIES FOR CROS 78
9.4 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 80
9.4.1 THIS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 80

10 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY REGION 82
10.1 INTRODUCTION 83
10.2 NORTH AMERICA 83
10.2.1 US 86
10.2.1.1 Strong economy and trend of early adoption of technologies are driving market growth in the US 86
10.2.2 CANADA 89
10.2.2.1 Growing research on AI technologies and emergence of new AI-based start-ups will support the market in Canada 89
10.2.3 MEXICO 91
10.2.3.1 Government initiatives will support market growth in Mexico 91
10.3 EUROPE 92
10.3.1 UK 95
10.3.1.1 The UK holds the largest share of the European market 95
10.3.2 GERMANY 98
10.3.2.1 Government support and favorable training programs are major market drivers in Germany 98
10.3.3 FRANCE 99
10.3.3.1 Strong government support and favorable strategies & initiatives form key drivers of the market in France 99
10.3.4 REST OF EUROPE 101
10.4 ASIA PACIFIC 103
10.4.1 JAPAN 105
10.4.1.1 Japan dominates the APAC market for AI in drug discovery 105
10.4.2 CHINA 106
10.4.2.1 Growing CMOs market and cross-industry collaborations are factors responsible for the growth of the market in China 106
10.4.3 INDIA 108
10.4.3.1 Steady adoption of AI technologies will drive market growth in India 108
10.4.4 REST OF ASIA PACIFIC 110
10.5 REST OF THE WORLD 112

11 COMPETITIVE LANDSCAPE 114
11.1 OVERVIEW 114
11.2 MARKET SHARE ANALYSIS 116
11.3 COMPETITIVE LEADERSHIP MAPPING 117
11.3.1 VISIONARY LEADERS 117
11.3.2 DYNAMIC DIFFERENTIATORS 117
11.3.3 INNOVATORS 117
11.3.4 EMERGING COMPANIES 117
11.4 COMPETITIVE SITUATION AND TRENDS 119
11.4.1 PRODUCT LAUNCHES AND ENHANCEMENTS 119
11.4.2 EXPANSIONS 119
11.4.3 ACQUISITIONS 120
11.4.4 OTHER STRATEGIES 120

12 COMPANY PROFILES 121
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 MICROSOFT CORPORATION 121
12.2 NVIDIA CORPORATION 123
12.3 IBM CORPORATION 125
12.4 GOOGLE (A SUBSIDIARY OF ALPHABET INC.) 127
12.5 ATOMWISE, INC. 130
12.6 DEEP GENOMICS 132
12.7 CLOUD PHARMACEUTICALS, INC. 133
12.8 INSILICO MEDICINE 134
12.9 BENEVOLENTAI 135
12.10 EXSCIENTIA 136
12.11 CYCLICA 138
12.12 BIOAGE 140
12.13 NUMERATE 141
12.14 NUMEDII, INC. 142
12.15 ENVISAGENICS 143
12.16 TWOXAR, INCORPORATED 144
12.17 OWKIN, INC. 145
12.18 XTALPI, INC. 146
12.19 VERGE GENOMICS 147
12.20 BERG LLC 148
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX 149
13.1 DISCUSSION GUIDE 149
13.2 KNOWLEDGE STORE:  152
13.3 AVAILABLE CUSTOMIZATIONS 154
13.4 RELATED REPORTS 154
13.5 AUTHOR DETAILS 155



List of Figures



FIGURE 1 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY: MARKET SEGMENTATION 18
FIGURE 2 RESEARCH DESIGN 21
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS 25
FIGURE 4 BOTTOM-UP APPROACH 27
FIGURE 5 TOP-DOWN APPROACH 27
FIGURE 6 DATA TRIANGULATION METHODOLOGY 28
FIGURE 7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING 2019 VS. 2024 (USD MILLION) 30
FIGURE 8 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2019–2024 31
FIGURE 9 ARTIFICIAL LEARNING IN DRUG DISCOVERY MARKET, BY APPLICATION 2019 VS. 2024 (USD MILLION) 32
FIGURE 10 ARTIFICIAL LEARNING IN DRUG DISCOVERY MARKET, BY END USER 2019 VS. 2024 (USD MILLION) 33
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET 34
FIGURE 12 NEED TO CONTROL DRUG DISCOVERY & DEVELOPMENT COSTS IS A MAJOR FACTOR DRIVING THE ADOPTION OF AI IN DRUG DISCOVERY SOLUTIONS 35
FIGURE 13 SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 36
FIGURE 14 DEEP LEARNING SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE
IN 2018 37
FIGURE 15 NORTH AMERICA IS THE FASTEST-GROWING REGIONAL MARKET FOR AI IN DRUG DISCOVERY 38
FIGURE 16 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 39
FIGURE 17 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG
DISCOVERY MARKET SNAPSHOT 84
FIGURE 18 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SNAPSHOT 93
FIGURE 19 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES 114
FIGURE 20 MARKET EVOLUTION FRAMEWORK 115
FIGURE 21 AI IN DRUG DISCOVERY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018 116
FIGURE 22 COMPETITIVE LEADERSHIP MAPPING OF THE AI IN DRUG DISCOVERY MARKET 118
FIGURE 23 MICROSOFT CORPORATION: COMPANY SNAPSHOT 121
FIGURE 24 NVIDIA CORPORATION: COMPANY SNAPSHOT 123
FIGURE 25 IBM CORPORATION: COMPANY SNAPSHOT 125
FIGURE 26 ALPHABET: COMPANY SNAPSHOT 127

 

List of Tables



TABLE 1 INDICATIVE LIST OF COLLABORATIONS AND PARTNERSHIPS (2017–2019) 40
TABLE 2 INDICATIVE LIST OF DRUGS LOSING PATENT IN 2019 41
TABLE 3 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING 2017–2024 (USD MILLION) 44
TABLE 4 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE BY REGION, 2017–2024 (USD MILLION) 45
TABLE 5 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE, BY COUNTRY, 2017–2024 (USD MILLION) 45
TABLE 6 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE, BY COUNTRY, 2017–2024 (USD MILLION) 45
TABLE 7 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE, BY COUNTRY, 2017–2024 (USD MILLION) 46
TABLE 8 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES BY REGION, 2017–2024 (USD MILLION) 46
TABLE 9 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES, BY COUNTRY, 2017–2024 (USD MILLION) 47
TABLE 10 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES, BY COUNTRY, 2017–2024 (USD MILLION) 47
TABLE 11 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES BY COUNTRY, 2017–2024 (USD MILLION) 47
TABLE 12 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 49
TABLE 13 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2017–2024 (USD MILLION) 50
TABLE 14 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 15 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 50
TABLE 16 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 51
TABLE 17 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 51
TABLE 18 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING BY REGION, 2017–2024 (USD MILLION) 52
TABLE 19 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 52
TABLE 20 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 53
TABLE 21 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 53
TABLE 22 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SUPERVISED LEARNING, BY REGION, 2017–2024 (USD MILLION) 54
TABLE 23 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 54
TABLE 24 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 55
TABLE 25 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 55
TABLE 26 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2017–2024 (USD MILLION) 56
TABLE 27 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 56
TABLE 28 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 29 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 30 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2017–2024 (USD MILLION) 58
TABLE 31 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 58
TABLE 32 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 58
TABLE 33 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION) 59
TABLE 34 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY REGION, 2017–2024 (USD MILLION) 59
TABLE 35 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY 2017–2024 (USD MILLION) 60
TABLE 36 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 37 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 38 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2017–2024 (USD MILLION) 61
TABLE 39 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION) 61
TABLE 40 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION) 62
TABLE 41 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION) 62
TABLE 42 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION 2017–2024 (USD MILLION) 64
TABLE 43 INDICATIVE LIST OF INITIATIVES IN IMMUNO-ONCOLOGY DRUG DEVELOPMENT 65
TABLE 44 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR IMMUNO-ONCOLOGY, BY REGION, 2017–2024 (USD MILLION) 65
TABLE 45 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR IMMUNO-ONCOLOGY, BY COUNTRY, 2017–2024 (USD MILLION) 65
TABLE 46 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR IMMUNO-ONCOLOGY, BY COUNTRY, 2017–2024 (USD MILLION) 66
TABLE 47 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR IMMUNO-ONCOLOGY, BY COUNTRY, 2017–2024 (USD MILLION) 66
TABLE 48 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR NEURODEGENERATIVE DISEASES, BY REGION, 2017–2024 (USD MILLION) 67
TABLE 49 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2017–2024 (USD MILLION) 67
TABLE 50 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2017–2024 (USD MILLION) 68
TABLE 51 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2017–2024 (USD MILLION) 68
TABLE 52 INDICATIVE LIST OF DEVELOPMENTS IN CARDIOVASCULAR DRUG DEVELOPMENT 69
TABLE 53 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2017–2024 (USD MILLION) 69
TABLE 54 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017–2024 (USD MILLION) 69
TABLE 55 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017–2024 (USD MILLION) 70
TABLE 56 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017–2024 (USD MILLION) 70
TABLE 57 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR METABOLIC DISEASES, BY REGION, 2017–2024 (USD MILLION) 71
TABLE 58 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2017–2024 (USD MILLION) 71
TABLE 59 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2017–2024 (USD MILLION) 71
TABLE 60 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2017–2024 (USD MILLION) 72
TABLE 61 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION) 72
TABLE 62 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 73
TABLE 63 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 73
TABLE 64 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 73
TABLE 65 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 75
TABLE 66 INDICATIVE LIST OF DEVELOPMENTS 76
TABLE 67 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION) 76
TABLE 68 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY 2017–2024 (USD MILLION) 77
TABLE 69 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY 2017–2024 (USD MILLION) 77
TABLE 70 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY 2017–2024 (USD MILLION) 77
TABLE 71 INDICATIVE LIST OF COLLABORATIONS WITH CROS 78
TABLE 72 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2017–2024 (USD MILLION) 78
TABLE 73 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 79
TABLE 74 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 79
TABLE 75 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 79
TABLE 76 INDICATIVE LIST OF RESEARCH COLLABORATIONS 80
TABLE 77 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION 2017–2024 (USD MILLION) 80
TABLE 78 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET
FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2017–2024 (USD MILLION) 81
TABLE 79 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR
RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2017–2024 (USD MILLION) 81
TABLE 80 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR
RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2017–2024 (USD MILLION) 81
TABLE 81 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY REGION 2017–2024 (USD MILLION) 83
TABLE 82 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY COUNTRY, 2017–2024 (USD MILLION) 85
TABLE 83 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY OFFERING, 2017–2024 (USD MILLION) 85
TABLE 84 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY TECHNOLOGY, 2017–2024 (USD MILLION) 85
TABLE 85 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY APPLICATION, 2017–2024 (USD MILLION) 86
TABLE 86 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY END USER, 2017–2024 (USD MILLION) 86
TABLE 87 US: INDICATIVE LIST OF STRATEGIC DEVELOPMENTS 87
TABLE 88 US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 87
TABLE 89 US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 88
TABLE 90 US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 88
TABLE 91 US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 88
TABLE 92 CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 89
TABLE 93 CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY TECHNOLOGY, 2017–2024 (USD MILLION) 90
TABLE 94 CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY APPLICATION, 2017–2024 (USD MILLION) 90
TABLE 95 CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 90
TABLE 96 MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 91
TABLE 97 MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY TECHNOLOGY, 2017–2024 (USD MILLION) 91
TABLE 98 MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY APPLICATION, 2017–2024 (USD MILLION) 92
TABLE 99 MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 92
TABLE 100 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 94
TABLE 101 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 94
TABLE 102 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY TECHNOLOGY, 2017–2024 (USD MILLION) 94
TABLE 103 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY APPLICATION, 2017–2024 (USD MILLION) 95
TABLE 104 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 95
TABLE 105 UK: INDICATIVE LIST OF STRATEGIC DEVELOPMENTS 96
TABLE 106 UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 96
TABLE 107 UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 97
TABLE 108 UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 97
TABLE 109 UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 97
TABLE 110 GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY OFFERING, 2017–2024 (USD MILLION) 98
TABLE 111 GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY TECHNOLOGY, 2017–2024 (USD MILLION) 98
TABLE 112 GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY APPLICATION, 2017–2024 (USD MILLION) 99
TABLE 113 GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY END USER, 2017–2024 (USD MILLION) 99
TABLE 114 FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 100
TABLE 115 FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY TECHNOLOGY, 2017–2024 (USD MILLION) 100
TABLE 116 FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY APPLICATION, 2017–2024 (USD MILLION) 100
TABLE 117 FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 101
TABLE 118 ROE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 101
TABLE 119 ROE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 102
TABLE 120 ROE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 102
TABLE 121 ROE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 102
TABLE 122 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 103
TABLE 123 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 103
TABLE 124 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 104
TABLE 125 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 104
TABLE 126 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 104
TABLE 127 JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 105
TABLE 128 JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 105
TABLE 129 JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 106
TABLE 130 JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 106
TABLE 131 CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 107
TABLE 132 CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 107
TABLE 133 CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 108
TABLE 134 CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 108
TABLE 135 INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 109
TABLE 136 INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 109
TABLE 137 INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 109
TABLE 138 INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 110
TABLE 139 ROAPAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 110
TABLE 140 ROAPAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY TECHNOLOGY, 2017–2024 (USD MILLION) 111
TABLE 141 ROAPAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET BY APPLICATION, 2017–2024 (USD MILLION) 111
TABLE 142 ROAPAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 111
TABLE 143 ROW: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION) 112
TABLE 144 ROW: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 112
TABLE 145 ROW: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 113
TABLE 146 ROW: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION) 113
TABLE 147 PRODUCT LAUNCHES AND ENHANCEMENTS, 2016–2019 119
TABLE 148 EXPANSIONS, 2016–2019 119
TABLE 149 ACQUISITIONS, 2016–2019 120
TABLE 150 OTHER STRATEGIES, 2016–2019 120